Short interest for Aptinyx Inc Com gives investors a sense of the degree to which investors are betting on the decline of Aptinyx Inc Com's stock. Short interest data is updated every two weeks.

Aptinyx Inc Com Stock (OTC:APTX), Short Interest Report

Aptinyx

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ACMR

AFRM

AGBA

ALTI

APTX

ASNS

ATSG

BAOS

BILL

CDLX

COIN

CVNA

DCFC

DKNG

DMTK

DOGZ

FNKO

FORR

FOXF

FUBO

FYBR

GDYN

GLMD

HCDI

INVE

LASR

LEJU

LFVN

LYFT

MDJH

MINM

MPLN

MPWR

MYGN

NBTX

OPEN

PACW

PRLB

QRTEB

RDFN

RILY

SDGR

SNGX

SPXC

SVFD

TEAM

TNDM

TRUP

VCIG

ZAPP

ZION

Why Atlassian Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

Biotech

Health Care

General

Aptinyx Evaluates Strategic Alternatives For Its Future After Failed Trials, 60% Layoffs

Pre-Market Outlook

AMPE

BOXD

BRDS

CETY

DHHC

DRMA

FLGC

HLBZ

HRTX

HTGM

IRON

NOTE

OUST

SYTA

TCBP

TRKA

VORB

Gainers


	Bird Global, Inc. (NYSE: BRDS) shares rose 58.7% to $0.2250 in pre-market trading after gaining more than 17% on Thursday. Bird announced plans to expand across Greater Toronto area this spring.


Why Heron Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Aptinyx Inc Com

Denny&#8217;s Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DENN#NASDAQ">DENN</a>) reported weaker-than-expected first-quarter <a href="https://www.benzinga.com/quote/DENN/earnings">financial results on Tuesday.</a>
Denny&#8217;s posted adjusted earnings of 11 cents per share, missing market estimates of 14 cents per share. The company's quarterly sales came in at $110.00 million, missing expectations of $115.16 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Kelli Valade, Chief Executive Officer, stated, &#8220;I am very pleased that our first quarter domestic same-restaurant sales and traffic outperformed both the family and casual dining segments, while overcoming the industry&#8217;s tough operating environment. We were also excited for Keke&#8217;s to expand outside of Florida and begin testing our new design in the latest Florida openings. I am encouraged by the sales driving initiatives planned for the back half of the year including expanding our third virtual brand, Banda Burrito, launching our test with Franklin Junction, reigniting our Denny&#8217;s remodel program and having the full force of our local co-op advertising fund for the first time since the pandemic began. These initiatives are sure to generate incremental sales and margins at our flagship brand.&#8221;
Denny&#8217;s shares fell 2.3% to close at $8.02 on Tuesday.
These analysts made changes to their price targets on Denny&#8217;s following earnings announcement.
<ul>
<li>Wedbush cut the price target on Denny&#8217;s from $9.5 to $8.5. Wedbush analyst Nick Setyan maintained a Neutral rating.</li>
<li>Oppenheimer slashed the price target on Denny&#8217;s from $12 to $11. Oppenheimer analyst Michael Tames maintained an Outperform rating.</li>
</ul>
Read Next: <a href="http://nxp">This Analyst With 86% Accuracy Rate Sees More Than 24% Upside In Lattice Semiconductor &#8211; Here Are 5 Stock Picks For April From Wall Street&#8217;s Most Accurate Analysts</a>

Earnings

Price Target

DENN

Denny's Analysts Cut Their Forecasts After Q1 Earnings

Standard Motor Products (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMP#NYSE">SMP</a>) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.37 by 21.62 percent. This is a 26.23 percent decrease over earnings of $0.61 per share from the same period last year. The company reported quarterly sales of $331.40 million which beat the analyst consensus estimate of $321.84 million by 2.97 percent. This is a 1.03 percent increase over sales of $328.03 million the same period last year.

Earnings Beats

Standard Motor Products Q1 Adj $0.45 Beats $0.37 Estimate, Sales $331.40M Beat $321.84M Estimate

Guidance

National Retail Props Sees FY24 Core FFO $3.25-$3.31

Low-dose LTI-03 (2.5 mg BID), a Caveolin-1 related peptide, reduced expression of multiple profibrotic proteins in both pathological basal-like cells and fibroblasts and increased the expression of a biomarker indicative of epithelial health, suggesting potential therapeutic effect &nbsp;
Positive trend was observed in seven of eight IPF biomarkers evaluated
Low-dose LTI-03 was well-tolerated, with no safety signal observed
Data from Cohort 2 evaluating high-dose LTI-03 (5 mg BID) is expected in the third quarter of 2024
Company to host conference call on Wednesday, May 1st at 9:00 am ET

ALRN

Aileron Therapeutics Announces Data From Cohort 1 Of Phase 1b Clinical Trial Of LTI-03 In Idiopathic Pulmonary Fibrosis

Rosenblatt analyst Kevin Cassidy maintains Skyworks Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKS#NASDAQ">SWKS</a>) with a Buy and lowers the price target from $130 to $120.

Analyst Ratings

SWKS

Rosenblatt Maintains Buy on Skyworks Solutions, Lowers Price Target to $120

Truist Securities analyst Michael Ciarmoli maintains Albany Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIN#NYSE">AIN</a>) with a Buy and lowers the price target from $121 to $104.

Truist Securities Maintains Buy on Albany Intl, Lowers Price Target to $104

BrightSpire Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRSP#NYSE">BRSP</a>) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.18 by 27.78 percent.

BRSP

BrightSpire Capital Q1 2024 Adj EPS $0.23 Beats $0.18 Estimate

PALI

Palisade Bio Announces Completion Of An Analysis On PALI-2108; Says 'Findings from the study demonstrated that PALI-2108 exhibited efficacy in inhibiting TNF-α production induced by LPS in this ex-vivo peripheral whole blood assay.'

Truist Securities analyst William Stein maintains Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) with a Hold and lowers the price target from $174 to $162.

Truist Securities Maintains Hold on Advanced Micro Devices, Lowers Price Target to $162

National Retail Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NNN#NYSE">NNN</a>) reported quarterly earnings of $0.83 per share which beat the analyst consensus estimate of $0.82 by 1.22 percent. The company reported quarterly sales of $215.407 million which beat the analyst consensus estimate of $211.462 million by 1.87 percent. This is a 5.54 percent increase over sales of $204.108 million the same period last year.

National Retail Props Q1 2024 FFO $0.83 Beats $0.82 Estimate, Sales $215.407M Beat $211.462M Estimate

Small Cap Consumer Research analyst Eric Beder reiterates Urban-gro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) with a Buy and maintains $8 price target.

Reiteration

UGRO

Small Cap Consumer Research Reiterates Buy on Urban-gro, Maintains $8 Price Target

On Wednesday,&nbsp;CleanCore Solutions, Inc&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZONE#NYSE">ZONE</a>) announced that, following a successful pilot, it has expanded its relationship with&nbsp;Harry Reid International Airport&nbsp;in Las Vegas.
It deployed additional&nbsp;<a target="_blank" href="https://www.cleancoresol.com/product/power-caddy/" rel="noreferrer noopener">Power Caddies</a>, the Company's portable units for producing its patented, aqueous ozone solution for chemical-free, safe&nbsp;and&nbsp;cost-effective disinfection and cleaning of any surface.&nbsp;
What Happened?&nbsp;Doug Moore, CEO of CleanCore, stated, "We believe this expanded partnership demonstrates our ability to not only sell but evolve and expand our client relationships as they witness the efficacy and cost savings of our technology."
Why Does It Matter?&nbsp;Sam Torrence, Airport Manager of Custodial Operations, Terminal Operations Division at Harry Reid International Airport, commented, "CleanCore's Power Caddy has checked all the boxes for us,&nbsp;in terms of safety, sustainability, and&nbsp;a&nbsp;technology that is user-friendly&nbsp;for our team members."
Price Action: ZONE shares closed lower by 3.13% at $3.10 Tuesday.
Photo via Company

Market-Moving Exclusives

Exclusives

ZONE

EXCLUSIVE: CleanCore Expands Eco-Friendly Cleaning Solutions at Las Vegas Harry Reid International Airport

Events

ARDX

Ardelyx To Present Additional Data For XPHOZAH For Adults With Chronic Kidney Disease On Dialysis At National Kidney Foundation 2024 Spring Clinical Meetings

In an escalation of tensions between Congress and the U.S. Securities and Exchange Commission (SEC), <span style="font-size: revert; color: var(--tw-prose-body); font-family: Söhne, ui-sans-serif, system-ui, -apple-system, &quot;Segoe UI&quot;, Roboto, Ubuntu, Cantarell, &quot;Noto Sans&quot;, sans-serif, &quot;Helvetica Neue&quot;, Arial, &quot;Apple Color Emoji&quot;, &quot;Segoe UI Emoji&quot;, &quot;Segoe UI Symbol&quot;, &quot;Noto Color Emoji&quot;;">Patrick McHenry (R-N.C.), Chair of the House Financial Services Committee, has openly criticized <a href="https://www.benzinga.com/markets/cryptocurrency/24/03/37538468/sec-chair-gary-gensler-declines-to-say-whether-ethereum-is-a-commodity-its-about-circumsta">SEC Chair Gary Gensler</a> for his evasive responses during a congressional hearing. 
What Happened: McHenry <a href="https://twitter.com/PatrickMcHenry/status/1785317163110130028">alleged</a> that Gensler knowingly avoided clarifying whether the SEC considers Ethereum&#8216;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) cryptocurrency, ether, as a security. 
This accusation was spurred by revelations from court documents indicating the SEC was actively investigating ether&#8217;s status just before Gensler&#8217;s testimony.
&#8220;The refusal of Chair Gensler to address questions about the SEC's stance on ether during the hearing appears to be a deliberate misrepresentation of the agency&#8217;s position,&#8221; McHenry asserted on social media platform X, referring to evidence presented in a lawsuit filed by blockchain company Consensys.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/"><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/27091545/Benzinga-conference.gif" alt="Benzinga future of digital assets conference" class="wp-image-267246" /></a></figure>
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38546670/us-stablecoin-regulation-talks-stall-but-progress-is-near">US Stablecoin Regulation Talks Stall, But Progress Is Near</a>
The debate over whether ether should be classified as a security is not just a legal technicality; it carries significant implications for the broader cryptocurrency market. Should ether be deemed a security, it could set a precedent for the regulation of numerous other digital tokens, potentially stifling innovation and investment within the sector.
In response to these developments, crypto attorney Grant Gulovsen offered a perspective that highlights the complexities of the SEC&#8217;s investigative processes. 
&#8220;The initiation of an investigation by the SEC does not necessarily equate to an official stance or determination,&#8221; Gulovsen explained, indicating that the SEC's inquiry into ether does not confirm its classification as a security.
As these events unfold, the discussion around digital assets continues to evolve, emphasizing the <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38461470/fbi-issues-warning-against-unregistered-crypto-services-amid-privacy-concerns">importance of regulatory clarity</a>. 
What&#8217;s Next: This topic is also poised to be a focal point at Benzinga&#8217;s upcoming <a href="https://www.benzinga.com/events/digital-assets/agenda/">Future of Digital Assets</a> event on Nov. 19.
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38538169/bitcoin-grinds-lower-catalysts-traders-will-watch-for-their-next-moves">Bitcoin Grinds Lower: Catalysts Traders Will Watch For Their Next Moves</a>
Image created using artificial intelligence with Midjourney.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$ETH

Patrick McHenry Questions SEC's Transparency On Ethereum As A Security

Rosenblatt analyst Hans Mosesmann maintains Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) with a Buy and maintains $250 price target.

Rosenblatt Maintains Buy on Advanced Micro Devices, Maintains $250 Price Target

EXCLUSIVE: CleanCore Solutions Tells Benzinga Co Expands Relationship With Harry Reid International Airport With Installation Of Additional Power Caddy Units Following Successful Pilot

Contracts

RAMP

Environics And LiveRamp Technology Partner; Environics Analytics To Be Sole Provider Of LiveRamp's Suite Of Products And Services In Canada

Additional data from the Phase 2 ARCHER trial demonstrating protection of visual acuity and anatomical structure following ANX007 treatment will be featured as an oral presentation &nbsp;
New preclinical data on the pathogenic role of C1q on photoreceptor synapse elimination and the protection of photoreceptors and their function from C1q blockade in GA will be featured as a poster presentation

ANNX

Annexon To Present Data Of Additional Phas3 2 Clinical Results Of ANX007 From ARCHER Trial In Geographic Atrophy Including Further Analyses Of Visual Acuity And Photoreceptor Preservation At ARVO 2024 Annual Meeting

Rosenblatt analyst Barton Crockett maintains Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) with a Buy and maintains $220 price target.

AMZN

Rosenblatt Maintains Buy on Amazon.com, Maintains $220 Price Target

Wedbush analyst Nick Setyan maintains Brinker International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAT#NYSE">EAT</a>) with a Neutral and raises the price target from $47 to $56.

Wedbush Maintains Neutral on Brinker International, Raises Price Target to $56

Press Releases

Tentarix Biotherapeutics Announces the Appointment of Andrew D. Kidd, MD, CFA, as CEO